Aarey Drugs & Pharmaceuticals Share Price

  • 47.900.86 (1.81%)
  • Volume: 36,271
  • Live
  • Last Updated On: 02 Jul, 2024, 12:58 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Aarey Drugs & Pharmaceu...

  • 47.900.86 (1.81%)
  • Volume: 36,271
Advertisment

Aarey Drugs share price insights

View All

  • Company witnessed QoQ revenue growth of 180.7%, which is highest in the last 3 years. (Source: Standalone Financials)

  • Stock gave a 3 year return of 40.29% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

  • Stock generated 40.29% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

  • Aarey Drugs & Pharmaceuticals Ltd. share price moved up by 0.24% from its previous close of Rs 47.05. Aarey Drugs & Pharmaceuticals Ltd. stock last traded price is 47.16

    Share PriceValue
    Today/Current/Last47.16
    Previous Day47.0547.70

InsightsAarey Drugs

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		28.75
    EPS - TTM
    (₹)    		1.67
    MCap
    (₹ Cr.)    		132.30
    Sectoral MCap Rank
    		94
    PB Ratio
    (x)    		0.99
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    		-
    VWAP
    (₹)    		47.28
    52W H/L
    (₹)
    68.00 / 29.95

    Aarey Drugs Share Price Returns

    1 Day1.81%
    1 Week1.18%
    1 Month4.47%
    3 Months0.63%
    1 Year39.24%
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Aarey Drugs belongs to analysts' top-rated companies list?

    View Stock Screeners

    Aarey Drugs News & Analysis

    View all Aarey Drugs Share News & Announcements

    Aarey Drugs Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Aarey Drugs Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Aarey Drugs Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Quarterly Topline Performance

        Company witnessed QoQ revenue growth of 180.7%, which is highest in the last 3 years. (Source: Standalone Financials)
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income215.4976.7758.6751.65163.72
      Total Income Growth (%)180.7030.8613.58-68.45160.08
      Total Expenses212.1974.2556.3950.03160.56
      Total Expenses Growth (%)185.8031.6612.71-68.84161.10
      EBIT3.302.522.271.623.16
      EBIT Growth (%)30.7411.0740.36-48.80117.27
      Profit after Tax (PAT)2.151.020.780.720.36
      PAT Growth (%)110.5130.288.2899.70-26.61
      EBIT Margin (%)1.533.293.873.141.93
      Net Profit Margin (%)1.001.331.341.400.22
      Basic EPS (₹)0.770.400.310.290.14
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue402.58421.69495.43355.43306.78
      Total Revenue Growth (%)-4.53-14.8839.3915.86-14.57
      Total Expenses397.24415.68485.40347.13299.54
      Total Expenses Growth (%)-4.44-14.3639.8315.89-14.44
      Profit after Tax (PAT)4.683.776.546.515.79
      PAT Growth (%)24.20-42.380.4712.44-11.44
      Operating Profit Margin (%)2.452.112.443.083.00
      Net Profit Margin (%)1.180.901.321.861.93
      Basic EPS (₹)1.841.492.722.792.48

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets304.99291.32245.17233.04194.08
      Total Assets Growth (%)4.6918.825.2120.0733.19
      Total Liabilities172.22173.92131.53134.18101.74
      Total Liabilities Growth (%)-0.9832.23-1.9731.8971.97
      Total Equity132.77117.41113.6498.8692.35
      Total Equity Growth (%)13.083.3214.957.056.70
      Current Ratio (x)0.581.611.741.651.81
      Total Debt to Equity (x)0.240.320.120.180.19
      Contingent Liabilities0.00----

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities7.89-1.28-4.495.482.86
      Net Cash used in Investing Activities-7.320.44-2.20-2.88-0.92
      Net Cash flow from Financing Activities4.101.356.23-2.45-1.80
      Net Cash Flow4.680.51-0.460.150.13
      Closing Cash & Cash Equivalent1.590.710.190.650.50
      Closing Cash & Cash Equivalent Growth (%)125.90267.78-70.4629.2436.33
      Total Debt/ CFO (x)3.97-29.44-3.153.296.26

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)3.523.215.756.586.27
      Return on Capital Employed (%)7.107.2010.4410.689.62
      Return on Assets (%)1.531.292.662.792.98
      Interest Coverage Ratio (x)2.613.657.014.415.06
      Asset Turnover Ratio (x)1.331.562.06149.51154.61
      Price to Earnings (x)26.8115.9516.088.335.37
      Price to Book (x)0.940.510.920.550.34
      EV/EBITDA (x)13.599.298.506.154.89
      EBITDA Margin (%)2.882.492.843.343.30

      No reported Financial Ratios are available.

    Financial InsightsAarey Drugs

    • Income (P&L)

      • Quarterly Topline Performance

        Company witnessed QoQ revenue growth of 180.7%, which is highest in the last 3 years. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Aarey Drugs Peer Comparison

    • Aarey Drugs Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 40.29% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 40.29% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of 40.29% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 40.29% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Aarey Drugs28.751.013.527.101.534.202.451.181.840.580.243.97
          Brooks Labs-11.503.43-29.873.56-21.661.033.011.92-7.671.350.08-0.52
          Bafna Pharma26.792.439.0810.294.9729.086.324.813.111.750.302.57
          Bal Pharma26.432.8210.6620.862.3010.667.162.194.941.152.020.42
          Alpa Labs11.001.2211.0413.639.186.5719.3515.428.015.690.031.44
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Vaishali Pharma
          • Mangalam Drugs
          • Krebs Biochem
          • Ind Swift Ltd
          • Biofil Chem

          Choose from Stocks

            See All Parameters

          Peers InsightsAarey Drugs

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of 40.29% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 40.29% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Aarey Drugs Shareholding Pattern

          • QOQ Change

          • Total Shareholdings

          • Loading...
            Showing Aarey Drugs Shareholding as on 31 Mar 2024
            Category31 Mar 202431 Dec 202330 Sep 202330 Jun 2023
            Promoters45.2850.0450.0450.04
            Pledge0.000.000.000.00
            FII3.403.833.943.92
            DII0.000.000.000.00
            Mutual Funds0.000.000.000.00
            Others51.3246.1346.0246.04
          • Showing Shareholding as on 31 Mar 2024
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters1,27,02,44345.28 %-4.75
            Pledge00.00 %0.00
            FII9,54,7293.40 %-0.43
            Others1,43,97,13151.32 %5.18

          MF Ownership

          MF Ownership details are not available.

          Top Searches:

          Aarey Drugs News Aarey Drugs Quarterly Results Aarey Drugs Dividend Aarey Drugs Q1 ResultsAarey Drugs Q2 ResultsAarey Drugs Q3 ResultsAarey Drugs Q4 Results

          Corporate Actions

          • Aarey Drugs Board Meeting/AGM

          • Aarey Drugs Dividends

          • Others
          • Meeting DateAnnounced onPurposeDetails
            May 30, 2024May 23, 2024Board MeetingAudited Results
            Mar 27, 2024Mar 20, 2024Board MeetingOthers
            Feb 14, 2024Feb 06, 2024Board MeetingQuarterly Results
            Dec 29, 2023Dec 06, 2023EGM-
            Nov 11, 2023Nov 06, 2023Board MeetingQuarterly Results
          • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
            Interim1%0.1Dec 13, 2018Nov 30, 2018
          • All TypesEx-DateRecord DateAnnounced onDetails
            BonusJun 25, 2012Jun 26, 2012May 18, 2012Bonus Ratio: 1 share(s) for every 5 shares held
            RightsJan 19, 2012Jan 20, 2012Dec 17, 2009Rights ratio: 2 share for every 1 held at a price of Rs 25.0
            Splits--Aug 14, 2017Split: Old FV10.0| New FV:1.0

          About Aarey Drugs

          Aarey Drugs & Pharmaceuticals Ltd., incorporated in the year 1990, is a Small Cap company (having a market cap of Rs 132.00 Crore) operating in Pharmaceuticals sector. Aarey Drugs & Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals and Commission for the year ending 31-Mar-2023. Show More

          • Executives

          • Auditors

          • MR

            Mihir R Ghatalia

            Chairman & Managing Director
            NR

            Nimit Rajesh Ghatalia

            Executive Director
            AM

            Anil Mandal

            Independent Director
            CK

            Chetan K Mehta

            Independent Director
            Show More
          • Motilal & Associates LLP
            DMKH & Co

          Industry

          Pharma - Indian

          Key Indices Listed on

          -

          Address

          E-34, M.I.D.C.,Tarapur,Boisar,Thane, Maharashtra - 401506

          Contact

          [email protected]

          http://www.aareydrugs.com

          More Details

          FAQs about Aarey Drugs share

          • 1. What's the Aarey Drugs share price today?
            Aarey Drugs share price was Rs 47.98 as on 02 Jul, 2024, 12:42 PM IST. Aarey Drugs share price was up by 1.98% based on previous share price of Rs 46.97. Aarey Drugs share price trend:
            • Last 1 Month: Aarey Drugs share price moved up by 4.65%
            • Last 3 Months: Aarey Drugs share price moved up by 0.80%
            • Last 12 Months: Aarey Drugs share price moved up 39.48%
            • Last 3 Years: Aarey Drugs Share price moved remain unchanged by N.A.
          • 2. What is the PE & PB ratio of Aarey Drugs?
            The PE ratio of Aarey Drugs stands at 28.18, while the PB ratio is 0.99.
          • 3. What dividend is Aarey Drugs giving?
            Aarey Drugs & Pharmaceuticals Ltd. announced an equity dividend of 1% on a face value of 10.0 amounting to Rs 0.1 per share on 30 Nov 2018. The ex dividend date was 13 Dec 2018.
          • 4. What has been highest price of Aarey Drugs share in last 52 weeks?
            Aarey Drugs share price saw a 52 week high of Rs 68.00 and 52 week low of Rs 29.95.
          • 5. What is the CAGR of Aarey Drugs?
            The CAGR of Aarey Drugs is 3.23.
          • 6. How can I quickly analyze Aarey Drugs stock?
            Key Metrics for Aarey Drugs are:
            • PE Ratio of Aarey Drugs is 28.24
            • Price/Sales ratio of Aarey Drugs is 0.32
            • Price to Book ratio of Aarey Drugs is 0.99
          • 7. What are the returns for Aarey Drugs share?
            Return Performance of Aarey Drugs Shares:
            • 1 Week: Aarey Drugs share price moved up by 1.35%
            • 1 Month: Aarey Drugs share price moved up by 4.65%
            • 3 Month: Aarey Drugs share price moved up by 0.80%
            • 6 Month: Aarey Drugs share price moved down by 16.05%
          • 8. Who's the owner of Aarey Drugs?
            Following are the key changes to Aarey Drugs shareholding:
            • Promoter holding have gone down from 50.04 (30 Jun 2023) to 45.28 (31 Mar 2024)
            • Foreign Institutional Investors holding have gone down from 3.92 (30 Jun 2023) to 3.4 (31 Mar 2024)
            • Other investor holding has gone up from 46.04 (30 Jun 2023) to 51.32 (31 Mar 2024)
          • 9. What are the Aarey Drugs quarterly results?
            Total Revenue and Earning for Aarey Drugs for the year ending 2024-03-31 was Rs 402.58 Cr and Rs 4.68 Cr on Standalone basis. Last Quarter 2024-03-31, Aarey Drugs reported an income of Rs 215.49 Cr and profit of Rs 2.15 Cr.
          • 10. Who are peers to compare Aarey Drugs share price?
            Within Pharmaceuticals sector Aarey Drugs, Ind-Swift Ltd., Krebs Biochemicals & Industries Ltd., Biofil Chemicals & Pharmaceuticals Ltd., Mangalam Drugs and Organics Ltd., Bafna Pharmaceuticals Ltd., Alpa Laboratories Ltd., Vaishali Pharma Ltd., Bal Pharma Ltd., Brooks Laboratories Ltd. and Ortin Laboratories Ltd. are usually compared together by investors for analysis.
          • 11. What is the market cap of Aarey Drugs?
            Within the Pharmaceuticals sector, Aarey Drugs stock has a market cap rank of 94. Aarey Drugs has a market cap of Rs 134.66 Cr.
          • 12. Who is the chairman of Aarey Drugs?
            Mihir R Ghatalia is the Chairman & Managing Director of Aarey Drugs

          Trending in Markets

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Aarey Drugs Share Price
          The Economic Times